SAUHY logo

Straumann Holding AG (SAUHY) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, Straumann Holding AG (SAUHY) es una empresa del sector Healthcare valorada en 0. Calificado con 48/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 15 mar 2026
Puntuación de IA de 48/100

Straumann Holding AG (SAUHY) Resumen de Asistencia Médica y Tuberías

Empleados11,319
Sede CentralBasel, Switzerland

Straumann Holding AG, a Swiss-based company, is a global leader in the dental implant and orthodontic solutions market, offering a comprehensive portfolio of implant systems, CADCAM prosthetics, and clear aligners. With a strong international presence and a focus on innovation, Straumann serves a diverse range of clinical needs and patient segments.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 15 mar 2026

Tesis de Inversión

Straumann Holding AG presents a notable research candidate due to its leading position in the growing dental implant and orthodontic solutions market. The company's strong brand reputation, diverse product portfolio, and global reach provide a solid foundation for continued growth. With a P/E ratio of 21.21 and a profit margin of 13.7%, Straumann demonstrates financial stability and profitability. Key growth catalysts include the increasing demand for dental aesthetics, the aging global population, and the expansion of digital dentistry solutions. The company's commitment to innovation and strategic acquisitions further strengthens its competitive advantage. However, potential risks include regulatory changes, competition from established and emerging players, and economic downturns affecting discretionary healthcare spending.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market Cap of $16.72B reflects Straumann's strong position in the dental solutions market.
  • P/E ratio of 21.21 indicates investor confidence in Straumann's earnings potential.
  • Gross Margin of 70.1% demonstrates efficient cost management and premium pricing power.
  • ROE of 17.0% highlights Straumann's effective utilization of equity to generate profits.
  • Debt-to-Equity ratio of 19.35 indicates a conservative capital structure and manageable debt levels.

Competidores y Pares

Fortalezas

  • Global market leader in dental implants.
  • Strong brand reputation and customer loyalty.
  • Comprehensive product portfolio.
  • Extensive distribution network.

Debilidades

  • High price point compared to some competitors.
  • Dependence on developed markets.
  • Exposure to currency fluctuations.

Catalizadores

  • Ongoing: Increasing demand for dental implants and orthodontic solutions due to an aging global population.
  • Ongoing: Expansion of digital dentistry and clear aligner therapy markets.
  • Upcoming: Potential regulatory approvals for new products and technologies.
  • Ongoing: Strategic acquisitions to expand product portfolio and geographic reach.
  • Ongoing: Continued investment in research and development to drive innovation.

Riesgos

  • Potential: Intense competition from established and emerging players.
  • Potential: Regulatory changes and compliance requirements.
  • Potential: Economic downturns affecting discretionary healthcare spending.
  • Potential: Technological disruptions in the dental industry.
  • Ongoing: Currency fluctuations affecting international sales and profitability.

Oportunidades de crecimiento

  • Expansion in Emerging Markets: Straumann has a significant opportunity to expand its presence in emerging markets, particularly in Asia Pacific and Latin America. These regions are experiencing rapid economic growth and increasing demand for advanced dental solutions. By leveraging its existing distribution network and tailoring its product offerings to local market needs, Straumann can capture a larger share of these high-growth markets. This expansion could contribute significantly to revenue growth over the next 3-5 years.
  • Digital Dentistry Solutions: The increasing adoption of digital dentistry presents a significant growth opportunity for Straumann. The company's portfolio of intra-oral scanners, milling machines, and 3D printers enables dental professionals to streamline their workflows and improve treatment outcomes. By investing in research and development and expanding its digital solutions offerings, Straumann can capitalize on this growing trend and strengthen its competitive advantage. The digital dentistry market is expected to grow at a CAGR of 10-15% over the next 5 years.
  • Clear Aligner Therapy: Straumann's ClearCorrect business offers significant growth potential in the rapidly expanding clear aligner therapy market. Clear aligners are becoming increasingly popular among patients seeking a discreet and convenient alternative to traditional braces. By investing in marketing and expanding its ClearCorrect product line, Straumann can capture a larger share of this growing market. The clear aligner market is projected to reach $5 billion by 2028.
  • Strategic Acquisitions: Straumann has a history of successful acquisitions that have expanded its product portfolio and geographic reach. The company can continue to pursue strategic acquisitions to further strengthen its competitive position and accelerate growth. Potential acquisition targets include companies with complementary technologies, products, or distribution networks. These acquisitions can provide access to new markets, technologies, and customer segments.
  • Regenerative Solutions: Straumann's regenerative solutions for tooth preservation, implant-site management, and implant preservation represent a significant growth opportunity. As the focus on preventative dentistry increases, the demand for regenerative solutions is expected to grow. By investing in research and development and expanding its regenerative solutions portfolio, Straumann can capitalize on this growing trend and improve patient outcomes. The regenerative dentistry market is projected to grow at a CAGR of 8-10% over the next 5 years.

Oportunidades

  • Expansion in emerging markets.
  • Growth in digital dentistry and clear aligner therapy.
  • Strategic acquisitions to expand product portfolio.
  • Increasing demand for cosmetic dentistry.

Amenazas

  • Intense competition from established and emerging players.
  • Regulatory changes and compliance requirements.
  • Economic downturns affecting discretionary healthcare spending.
  • Technological disruptions in the dental industry.

Ventajas competitivas

  • Strong brand reputation and established market leadership in the dental implant market.
  • Comprehensive product portfolio covering a wide range of dental solutions.
  • Extensive global distribution network with a strong presence in key markets.
  • Commitment to innovation and research and development.
  • High switching costs for dental professionals due to training and familiarity with Straumann products.

Acerca de SAUHY

Founded in 1954 and headquartered in Basel, Switzerland, Straumann Holding AG has evolved into a global leader in tooth replacement and orthodontic solutions. The company operates through five segments: Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations. Straumann's comprehensive product portfolio includes dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions. These products are used in tooth correction, replacement, restoration, and prevention of tooth loss. Straumann offers a wide array of implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products. The company also provides prosthetics, including angled solutions, connections, components, and molar solutions. Straumann's digital solutions encompass intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers, along with consumables like blocks, discs, resins, titanium bases, and abutment blanks. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. Straumann serves clinicals needs, patient segments, and healthcare systems across the globe.

Qué hacen

  • Develops and manufactures dental implants for tooth replacement.
  • Offers CADCAM prosthetics for customized dental restorations.
  • Provides orthodontic solutions, including clear aligners, for teeth straightening.
  • Manufactures biomaterials for bone and tissue regeneration.
  • Offers digital equipment and solutions, such as intra-oral scanners and 3D printers.
  • Provides instruments and surgical sets for dental procedures.
  • Offers online education and training for dental professionals.

Modelo de Negocio

  • Sells dental implants, prosthetics, and orthodontic solutions to dental professionals and institutions.
  • Generates revenue through a network of distribution subsidiaries, partners, and third-party distributors.
  • Offers digital equipment and solutions with recurring revenue streams from consumables and software licenses.

Contexto de la Industria

Straumann Holding AG operates in the medical instruments and supplies industry, which is experiencing steady growth driven by an aging global population, increasing demand for cosmetic dentistry, and technological advancements in dental solutions. The market is competitive, with key players focusing on innovation, product differentiation, and geographic expansion. Straumann's strong brand reputation, comprehensive product portfolio, and global distribution network position it favorably within this landscape. The increasing adoption of digital dentistry and clear aligner therapies presents significant growth opportunities for companies like Straumann.

Clientes Clave

  • Dental professionals, including dentists, orthodontists, and oral surgeons.
  • Dental clinics and hospitals.
  • Dental laboratories.
Confianza de la IA: 81% Actualizado: 15 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Straumann Holding AG (SAUHY): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para SAUHY.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para SAUHY.

MoonshotScore

48/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de SAUHY en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Información de ADR de Straumann Holding AG No patrocinado

Straumann Holding AG (SAUHY) cotiza en los EE. UU. como un recibo de depósito estadounidense (ADR).

  • Nivel de ADR: 1
  • Ratio de ADR: 1:1
  • Ticker del mercado local: SAUH

Información del mercado OTC de SAUHY

The OTC Other tier represents the lowest tier of the OTC market, indicating that Straumann Holding AG (SAUHY) may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors, and the lack of stringent listing requirements can increase the risk of investing in these securities. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other securities, as they may be subject to greater price volatility and lower liquidity compared to exchange-listed stocks.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for SAUHY shares on the OTC market is likely limited, which can result in wider bid-ask spreads and increased price volatility. The trading volume may be low, making it difficult to buy or sell large quantities of shares without significantly impacting the price. Investors should be aware of these liquidity constraints and consider the potential impact on their investment strategy.
Factores de riesgo OTC:
  • Limited financial disclosure and transparency.
  • Lower liquidity and higher price volatility.
  • Potential for fraud or manipulation.
  • Lack of regulatory oversight compared to exchange-listed stocks.
  • Information asymmetry between the company and investors.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's growth prospects and potential risks.
  • Check for any legal or regulatory issues.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with investing in OTC securities.
Señales de legitimidad:
  • Established operating history as Straumann Holding AG since 1954.
  • Global presence and operations in multiple countries.
  • Leading market position in the dental implant industry.
  • Partnerships with reputable distributors and healthcare providers.
  • Presence of well-known brands such as Straumann, Neodent, and ClearCorrect.

SAUHY Preguntas Frecuentes sobre Acciones de Healthcare

¿Cuáles son los factores clave para evaluar SAUHY?

Straumann Holding AG (SAUHY) actualmente tiene una puntuación IA de 48/100, indicando puntuación baja. Fortaleza clave: Global market leader in dental implants.. Riesgo principal a monitorear: Potential: Intense competition from established and emerging players.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de SAUHY?

SAUHY actualmente puntúa 48/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de SAUHY?

Los precios de SAUHY se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre SAUHY?

La cobertura de analistas para SAUHY incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en SAUHY?

Las categorías de riesgo para SAUHY incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from established and emerging players.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de SAUHY?

La relación P/E para SAUHY compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está SAUHY sobrevalorada o infravalorada?

Determinar si Straumann Holding AG (SAUHY) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de SAUHY?

Straumann Holding AG (SAUHY) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • AI analysis pending may provide further insights.
  • OTC market data may be less reliable than exchange-listed data.
Fuentes de datos

Popular Stocks